Obesity paradox does exist
Jazyk angličtina Země Spojené státy americké Médium print
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy
PubMed
23882059
PubMed Central
PMC3920805
DOI
10.2337/dcs13-2023
PII: 36/Supplement_2/S276
Knihovny.cz E-zdroje
- MeSH
- index tělesné hmotnosti MeSH
- koronární nemoc komplikace epidemiologie patofyziologie MeSH
- lidé MeSH
- nadváha komplikace epidemiologie MeSH
- nutriční stav fyziologie MeSH
- obezita komplikace epidemiologie patofyziologie terapie MeSH
- složení těla fyziologie MeSH
- srdeční selhání komplikace patofyziologie MeSH
- tělesná výkonnost fyziologie MeSH
- tuková tkáň fyziologie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
Zobrazit více v PubMed
Flegal KM, Graubard BI, Williamson DF, Gail MH. Excess deaths associated with underweight, overweight, and obesity. JAMA 2005;293:1861–1867 PubMed
Gruberg L, Weissman NJ, Waksman R, et al. The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox? J Am Coll Cardiol 2002;39:578–584 PubMed
Romero-Corral A, Montori VM, Somers VK, et al. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet 2006;368:666–678 PubMed
Uretsky S, Messerli FH, Bangalore S, et al. Obesity paradox in patients with hypertension and coronary artery disease. Am J Med 2007;120:863–870 PubMed
Younge JO, Damen NL, van Domburg RT, Pedersen SS. Obesity, health status, and 7-year mortality in percutaneous coronary intervention: In search of an explanation for the obesity paradox. Int J Cardiol. 2 April 2012. [Epub ahead of print] PubMed
Hastie CE, Padmanabhan S, Slack R, et al. Obesity paradox in a cohort of 4880 consecutive patients undergoing percutaneous coronary intervention. Eur Heart J 2010;31:222–226 PubMed
Buchholz EM, Rathore SS, Reid KJ, et al. Body mass index and mortality in acute myocardial infarction patients. Am J Med 2012;125:796–803 PubMed PMC
Kovacic JC, Lee P, Baber U, et al. Inverse relationship between body mass index and coronary artery calcification in patients with clinically significant coronary lesions. Atherosclerosis 2012;221:176–182 PubMed PMC
Persy V, D’Haese P. Vascular calcification and bone disease: the calcification paradox. Trends Mol Med 2009;15:405–416 PubMed
Kalantar-Zadeh K, Block G, Horwich T, Fonarow GC. Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol 2004;43:1439–1444 PubMed
Curtis JP, Selter JG, Wang Y, et al. The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med 2005;165:55–61 PubMed
Fonarow GC, Srikanthan P, Costanzo MR, Cintron GB, Lopatin M, ADHERE Scientific Advisory Committee and Investigators An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108,927 patients in the Acute Decompensated Heart Failure National Registry. Am Heart J 2007;153:74–81 PubMed
Voulgari C, Tentolouris N, Dilaveris P, Tousoulis D, Katsilambros N, Stefanadis C. Increased heart failure risk in normal-weight people with metabolic syndrome compared with metabolically healthy obese individuals. J Am Coll Cardiol 2011;58:1343–1350 PubMed
Zapatero A, Barba R, Gonzalez N, et al. Influence of obesity and malnutrition on acute heart failure. Rev Esp Cardiol (Engl Ed) 2012;65:421–426 PubMed
Komukai K, Minai K, Arase S, et al. Impact of body mass index on clinical outcome in patients hospitalized with congestive heart failure. Circ J 2012;76:145–151 PubMed
Clark AL, Chyu J, Horwich TB. The obesity paradox in men versus women with systolic heart failure. Am J Cardiol 2012;110:77–82 PubMed PMC
Zamora E, Lupón J, de Antonio M, et al. The obesity paradox in heart failure: Is etiology a key factor? Int J Cardiol 2013;166:601–605 PubMed
Lainscak M, von Haehling S, Doehner W, Anker SD. The obesity paradox in chronic disease: facts and numbers. J Cachexia Sarcopenia Muscle 2012;3:1–4 PubMed PMC
Galal W, van Gestel YR, Hoeks SE, et al. The obesity paradox in patients with peripheral arterial disease. Chest 2008;134:925–930 PubMed
Barba R, Bisbe J, Pedrajas JN, et al. FRENA Investigators Body mass index and outcome in patients with coronary, cerebrovascular, or peripheral artery disease: findings from the FRENA registry. Eur J Cardiovasc Prev Rehabil 2009;16:457–463 PubMed
Vemmos K, Ntaios G, Spengos K, et al. Association between obesity and mortality after acute first-ever stroke: the obesity-stroke paradox. Stroke 2011;42:30–36 PubMed
Jackson RS, Black JH, 3rd, Lum YW, et al. Class I obesity is paradoxically associated with decreased risk of postoperative stroke after carotid endarterectomy. J Vasc Surg 2012;55:1306–1312 PubMed
Barba R, Zapatero A, Losa JE, et al. Riete Investigators Body mass index and mortality in patients with acute venous thromboembolism: findings from the RIETE registry. J Thromb Haemost 2008;6:595–600 PubMed
Stein PD, Matta F, Goldman J. Obesity and pulmonary embolism: the mounting evidence of risk and the mortality paradox. Thromb Res 2011;128:518–523 PubMed
Potapov EV, Loebe M, Anker S, et al. Impact of body mass index on outcome in patients after coronary artery bypass grafting with and without valve surgery. Eur Heart J 2003;24:1933–1941 PubMed
Aldhoon B, Wichterle D, Peichl P, Čihák R, Kautzner J. Complications of catheter ablation for atrial fibrillation in a high-volume centre with the use of intracardiac echocardiography. Europace 2013;15:24–32 PubMed
Hutagalung R, Marques J, Kobylka K, et al. The obesity paradox in surgical intensive care unit patients. Intensive Care Med 2011;37:1793–1799 PubMed
Mullen JT, Moorman DW, Davenport DL. The obesity paradox: body mass index and outcomes in patients undergoing nonbariatric general surgery. Ann Surg 2009;250:166–172 PubMed
Doehner W, Erdmann E, Cairns R, et al. Inverse relation of body weight and weight change with mortality and morbidity in patients with type 2 diabetes and cardiovascular co-morbidity: an analysis of the PROactive study population. Int J Cardiol 2012;162:20–26 PubMed
Sohn M-W, Budiman-Mak E, Oh EH, et al. Obesity paradox in amputation risk among nonelderly diabetic men. Obesity (Silver Spring) 2012;20:460–462 PubMed PMC
Landbo C, Prescott E, Lange P, Vestbo J, Almdal TP. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;160:1856–1861 PubMed
Blum A, Simsolo C, Sirchan R, Haiek S. “Obesity paradox” in chronic obstructive pulmonary disease. Isr Med Assoc J 2011;13:672–675 PubMed
Lainscak M, von Haehling S, Doehner W, et al. Body mass index and prognosis in patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease. J Cachexia Sarcopenia Muscle 2011;2:81–86 PubMed PMC
Kalantar-Zadeh K, Streja E, Molnar MZ, et al. Mortality prediction by surrogates of body composition: an examination of the obesity paradox in hemodialysis patients using composite ranking score analysis. Am J Epidemiol 2012;175:793–803 PubMed PMC
Martino JL, Stapleton RD, Wang M, et al. Extreme obesity and outcomes in critically ill patients. Chest 2011;140:1198–1206 PubMed PMC
Chang CS, Chang YF, Wang MW, et al. Inverse Relationship Between Central Obesity and Osteoporosis in Osteoporotic Drug Naive Elderly Females: The Tianliao Old People (TOP) Study. J Clin Densitom 2013;16:204–211 PubMed
Pischon T, Boeing H, Hoffmann K, et al. General and abdominal adiposity and risk of death in Europe. N Engl J Med 2008;359:2105–2120 PubMed
Calori G, Lattuada G, Piemonti L, et al. Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona Study. Diabetes Care 2011;34:210–215 PubMed PMC
Mathus-Vliegen EMH, Basdevant A, Finer N, et al. Obesity Management Task Force of the European Association for the Study of Obesity Prevalence, pathophysiology, health consequences and treatment options of obesity in the elderly: a guideline. Obes Facts 2012;5:460–483 PubMed
Lee CG, Fujimoto WY, Brunzell JD, et al. Intra-abdominal fat accumulation is greatest at younger ages in Japanese-American adults. Diabetes Res Clin Pract 2010;89:58–64 PubMed PMC
Hairston KG, Scherzinger A, Foy C, et al. Five-year change in visceral adipose tissue quantity in a minority cohort: the Insulin Resistance Atherosclerosis Study (IRAS) family study. Diabetes Care 2009;32:1553–1555 PubMed PMC
Snijder MB, Dekker JM, Visser M, et al. Associations of hip and thigh circumferences independent of waist circumference with the incidence of type 2 diabetes: the Hoorn Study. Am J Clin Nutr 2003;77:1192–1197 PubMed
Hassinen M, Lakka TA, Komulainen P, Haapala I, Nissinen A, Rauramaa R. Association of waist and hip circumference with 12-year progression of carotid intima-media thickness in elderly women. Int J Obes (Lond) 2007;31:1406–1411 PubMed
Debette S, Leone N, Courbon D, et al. Calf circumference is inversely associated with carotid plaques. Stroke 2008;39:2958–2965 PubMed
Heymsfield SB, Martin-Nguyen A, Fong TM, Gallagher D, Pietrobelli A. Body circumferences: clinical implications emerging from a new geometric model. Nutr Metab (Lond) 2008;5:24. PubMed PMC
Schenkeveld L, Magro M, Oemrawsingh RM, et al. The influence of optimal medical treatment on the ‘obesity paradox’, body mass index and long-term mortality in patients treated with percutaneous coronary intervention: a prospective cohort study. BMJ Open 2012;2:e000535. PubMed PMC
Oreopoulos A, Ezekowitz JA, McAlister FA, et al. Association between direct measures of body composition and prognostic factors in chronic heart failure. Mayo Clin Proc 2010;85:609–617 PubMed PMC
Stenholm S, Harris TB, Rantanen T, Visser M, Kritchevsky SB, Ferrucci L. Sarcopenic obesity: definition, cause and consequences. Curr Opin Nutr Metab Care 2008;11:693–700 PubMed PMC
Casas-Vara A, Santolaria F, Fernández-Bereciartúa A, González-Reimers E, García-Ochoa A, Martínez-Riera A. The obesity paradox in elderly patients with heart failure: analysis of nutritional status. Nutrition 2012;28:616–622 PubMed
Wannamethee SG, Shaper AG, Lennon L, Whincup PH. Decreased muscle mass and increased central adiposity are independently related to mortality in older men. Am J Clin Nutr 2007;86:1339–1346 PubMed
Hainer V, Toplak H, Stich V. Fat or fit: what is more important? Diabetes Care 2009;32(Suppl 2):S392–S397 PubMed PMC
McAuley PA, Artero EG, Sui X, et al. The obesity paradox, cardiorespiratory fitness, and coronary heart disease. Mayo Clin Proc 2012;87:443–451 PubMed PMC
Newman AB, Kupelian V, Visser M, et al. Strength, but not muscle mass, is associated with mortality in the health, aging and body composition study cohort. J Gerontol A Biol Sci Med Sci 2006;61:72–77 PubMed
Izawa KP, Watanabe S, Osada N, et al. Handgrip strength as a predictor of prognosis in Japanese patients with congestive heart failure. Eur J Cardiovasc Prev Rehabil 2009;16:21–27 PubMed
Kortelainen ML, Porvari K. Extreme obesity and associated cardiovascular disease verified at autopsy: time trends over 3 decades. Am J Forensic Med Pathol 2011;32:372–377 PubMed
Biasucci LM, Graziani F, Rizzello V, et al. Paradoxical preservation of vascular function in severe obesity. Am J Med 2010;123:727–734 PubMed
Fadini GP, Boscaro E, de Kreutzenberg S, et al. Time course and mechanisms of circulating progenitor cell reduction in the natural history of type 2 diabetes. Diabetes Care 2010;33:1097–1102 PubMed PMC
Graziani F, Biasucci LM, Cialdella P, et al. Thromboxane production in morbidly obese subjects. Am J Cardiol 2011;107:1656–1661 PubMed
Ledderose C, Kreth S, Beiras-Fernandez A. Ghrelin, a novel peptide hormone in the regulation of energy balance and cardiovascular function. Recent Pat Endocr Metab Immune Drug Discov 2011;5:1–6 PubMed
Rodríguez A, Gómez-Ambrosi J, Catalán V, et al. Association of plasma acylated ghrelin with blood pressure and left ventricular mass in patients with metabolic syndrome. J Hypertens 2010;28:560–567 PubMed
Lund LH, Williams JJ, Freda P, LaManca JJ, LeJemtel TH, Mancini DM. Ghrelin resistance occurs in severe heart failure and resolves after heart transplantation. Eur J Heart Fail 2009;11:789–794 PubMed PMC
Feldman AM, Combes A, Wagner D, et al. The role of tumor necrosis factor in the pathophysiology of heart failure. J Am Coll Cardiol 2000;35:537–544 PubMed
Heymsfield SB, Cefalu WT. Does body mass index adequately convey a patient’s mortality risk? JAMA 2013;309:87–88 PubMed